% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • going1green going1green Mar 7, 2013 7:57 PM Flag

    I Have LINK: Article : Analysts Raising CLDX Target. Roth Capital Says Buy with $16 Target. POSTED.

    US Market Buzz 3/7/13
    Analysts’ call: eBay Inc (NASDAQ:EBAY), Celldex Therapeutics, Inc. (NASDAQ:CLDX)
    March 7, 2013 by Karen Loftus in Technology
    In other news, Leerink Swann has initiated coverage for Celldex Therapeutics, Inc.(NASDAQ:CLDX) with a rating of Outperfrom. It set a price target of $18.

    Howard Liang, an analyst said that the range of Celldex Therapeutics is rare among small and mid-sized biotech enterprises, with 6 entirely owned clinical-stage biologics assets offering multiple shots on goal.

    A number of other companies have also commented on Celldex recently. Oppenheimer analysts have upped their price targets on the Celldex stock to $13 and have rated it an Outperform. Roth Capital analysts have reinstated a Buy rating on the Celldex shares and presently hold a price target of $16 on the stock.
    Cantor Fitzgerald analysts have also increased their price target on the biotech company’s stock to $13 and have rated it a Buy.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.58+0.25(+5.77%)May 31 4:00 PMEDT